The University of Medicine and Pharmacy of Craiova, via its Technology Transfer Center (CTT UMFCv), secured a perfect score of 100 points in UEFISCDI's national selection call for the 'Leadership TT – University Leadership for Knowledge and Technology Transfer' program. Funded through the 2021-2027 Education and Employment Program and co-financed by the European Union, this initiative seeks to boost universities' ability to turn research into impactful economic and social solutions, while consolidating ties with the business sector.

Achieving the maximum score confirms the institutional maturity of UMF Craiova in the field of technology transfer. It serves as a validation of how the university has built and developed the mechanisms through which research results can be leveraged for the benefit of society and the economy.

By participating in the Leadership TT program, the team of the Technology Transfer Center of UMF Craiova will benefit from mentorship and expertise provided by Oxentia, an organization originating from the University of Oxford, internationally recognized for its work in innovation management, entrepreneurship, and the commercialization of research results. This partnership grants our university access to models and best practices utilized by some of the world's highest-performing innovation ecosystems.

Beyond the recognition of institutional performance, this result sends a clear message to companies, entrepreneurs, and organizations interested in innovation: UMF Craiova is a partner ready to develop joint research and development, technology transfer, and innovation projects.

Alongside UMF Craiova, socio-economic partners can get involved in developing collaborative projects. Companies can contribute to defining innovative solutions, participate in developing and testing products, technologies, or services, and leverage the scientific expertise and research infrastructure available within the university.

The Technology Transfer Center of UMF Craiova facilitates the exact connection between researchers and the economic environment, identifies collaboration opportunities, and can transform research results into concrete applications with an impact on healthcare, biotechnology, medical devices, digital technologies, and other related fields. Examples of technologies and research results that can be transferred to the business environment include:

• Biotechnology and innovative cosmetic products: development of creams and cosmetic solutions based on plant extracts and hyaluronic acid, encapsulated in nanoparticles, featuring rapid absorption and increased efficacy, with no adverse effects on the skin;
• Medical devices: prototypes and technical solutions for diagnosis, monitoring, or medical assistance, developed within applied research projects;
• Innovative medical materials: dressings and bandages functionalized with antimicrobial and antifungal gels based on plant extracts, with potential application in infection prevention and accelerated wound healing;
• Digital health and artificial intelligence: AI-based algorithms and tools for optimizing diagnosis and personalized patient treatment tailored to individual profiles;
• Pharmaceutical biotechnology: formulations and molecules with therapeutic potential, preclinically tested, which can form the basis for the development of new pharmaceutical products;
• Personalized medicine and biomarkers: identification and validation of biomarkers useful in early diagnosis or in monitoring disease progression.

Prof. Dan Gheonea, PhD, Rector of the University of Medicine and Pharmacy of Craiova: “Achieving the maximum score in the Leadership TT program confirms that the University of Medicine and Pharmacy of Craiova possesses the necessary expertise, infrastructure, and human resources to transform research into solutions with real impact. Our goal is to develop the Technology Transfer Center into the primary meeting point between our researchers and the business community—a space where ideas are transformed into products, technologies, and services that benefit society. We invite interested companies to discover the collaboration opportunities we offer and to build together research and innovation projects with added value for both the economy and healthcare.”